Product
CELZ-201
1 clinical trial
3 indications
Indication
Type 1 DiabetesIndication
Diabetes MellitusIndication
Type 1Clinical trial
Clinical Trial to Evaluate the Safety and Efficacy of CELZ-201 in Patients With Recent Onset Type 1 Diabetes (CREATE-1)Status: Recruiting, Estimated PCD: 2025-01-31